Equine

Horses
The trademarks indicated by CAPITAL LETTERS in this publication are the property of, licensed to, promoted or distributed by Merck & Co., Inc., its subsidiaries or related companies. As used in this publication, the terms “Merck” and the “company” refer collectively to Merck & Co., Inc., the publicly held parent company, and its domestic and international subsidiaries, which are engaged in the discovery, development, manufacturing and marketing of pharmaceutical, animal health and consumer products worldwide.

Vaccines

PreveNile™

PreveNile provides active immunization of horses against West Nile virus infection. The live chimera virus vaccine is intended for the vaccination of healthy horses to prevent viremia and as an aid in the prevention of disease and encephalitis caused by West Nile virus infection. The vaccine is safe when used to vaccinate horses 4 months of age or older by the intramuscular route. A single dose of PreveNile has a duration of immunity of one year in yearlings and older horses. This vaccine is only available in the USA.



Equilis® Prequenza

Equilis® Prequenza provides active immunization of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection, and active immunization against tetanus to prevent mortality (Equilis Prequenza Te). Equilis Prequenza provides one year duration of immunity after revaccination. Equilis Prequenza contains ISCOM-Matrix as adjuvant and is available in ready to use syringes and vials
ProductDescription
EQUILIS PREQUENZAAn inactivated vaccine containing purified antigens of the hemaglutinin (HA) of both European and American type of Newmarket equine A/2 influenza virus in a saponin-based adjuvant. The vaccine is for the immunization of horses against equine influenza.
PREVENILEA vaccine to prevent viremia and aid in the prevention of disease and encephalitis caused by West Nile Virus infection in horses.